secwatch.observer — SEC 8-K summary
======================================

Issuer:     OLAPLEX HOLDINGS, INC. (OLPX)
CIK:        0001868726
Form:       8-K
Filed at:   2025-08-26T23:59:59+00:00
Accession:  0001193125-25-188088
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olaplex acquires biotech firm Purvala Bioscience for $10.5M in cash
-------------------------------------------------------------------

- Purchase price $10.5M, subject to adjustments; $1.05M escrowed for 15 months for indemnification.
- Purvala is a Boston biotech founded by MIT professor Dr. Bradley Olsen, focused on bioinspired molecules for health/beauty.
- This is Olaplex's first acquisition since its launch over 10 years ago, signaling renewed innovation push.
- Olaplex CEO Amanda Baldwin said Purvala tech could create 'next generation of disruptive science-backed product innovation'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868726/000119312525188088/0001193125-25-188088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868726/000119312525188088/d70869d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-188088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer